Tweets by AACE 2024 Annual Meeting

Obesity/Nutrition

Type here to filter the list

(3.03) Clinical Outcomes of a Tailored Exercise Intervention for Obese African-American Women

Favorite
(3.04) Evaluating the Association Between Early Body Weight Changes with Tirzepatide and Categorical Weight Reduction in People with Obesity or Overweight: a Post-Hoc Analysis

Favorite
(3.05) Waist-to-height ratio shifts over time in tirzepatide-treated participants – post hoc analysis in SURMOUNT-1 and SURMOUNT-2

Favorite
(3.06) A Case of Fatal Fulminant Necrotizing Pancreatitis in a Patient with Recent Tirzepatide Initiation

Favorite
(3.07) Assessing Preclinical Medical Students’ Perceptions of the Etiology of Obesity

Favorite
(3.08) Tirzepatide Improved Health-Related Quality of Life in Adults with Obesity or Overweight: Results from the SURMOUNT-3 phase 3 trial

Favorite
(3.09) Improvements in Physical Functioning Among Participants With Obesity With Limitations in Physical Function at Baseline: Results from SURMOUNT-1 and SURMOUNT-2 Trials

Favorite
(3.10) Tirzepatide Improves Health-Related Quality of Life in Participants With Obesity or Overweight and Type 2 Diabetes: Results From Phase 3 SURMOUNT-2 Trial

Favorite
(3.14) Qualitative Insights on Meaningful Change in Physical Functioning in SURMOUNT-4 Participants

Favorite
(3.15) The Sapien Lifestyle and Its Effects on the Markers of Metabolic Disease

Favorite